AAUM (Average Assets Under Management) of ₹263.63 Cr for Jul-Sep 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 70.4% | 70.5% | ● +0.0% |
| Healthcare Services | 20.6% | 21.1% | ▲ +0.5% |
| Industrial Products | 2.2% | 1.9% | ▼ -0.3% |
| Healthcare Equipment & Supplies | 1.3% | 1.5% | ▲ +0.2% |
| Chemicals & Petrochemicals | 1.3% | 1.1% | ▼ -0.2% |
| Retailing | 0.0% | 0.9% | ▲ +0.9% |
| Aerospace & Defense | 0.5% | 0.5% | ● -0.1% |
| Banks | 0.5% | 0.5% | ● -0.1% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 70.5% | 74.8% | ▲ +4.3% |
| Healthcare Services | 21.1% | 20.9% | ▼ -0.2% |
| Healthcare Equipment & Supplies | 1.5% | 1.5% | ● 0.0% |
| Industrial Products | 1.9% | 1.2% | ▼ -0.7% |
| Chemicals & Petrochemicals | 1.1% | 0.9% | ▼ -0.2% |
| Aerospace & Defense | 0.5% | 0.0% | ▼ -0.5% |
| Banks | 0.5% | 0.0% | ▼ -0.5% |
| Retailing | 0.9% | 0.0% | ▼ -0.9% |
Comparing Jul 2026 → Sep 2026
| # | Stock | Sector | Weight (Sep 2026) |
|---|---|---|---|
| 1 | Anthem Biosciences Limited ₹3.32 Cr |
Pharmaceuticals & Biotechnology | 1.25% |
| 2 | Gland Pharma Limited ₹2.74 Cr |
Pharmaceuticals & Biotechnology | 1.03% |
| 3 | Metropolis Healthcare Limited ₹1.89 Cr |
Healthcare Services | 0.71% |
| # | Stock | Sector | Last Weight (Jul 2026) |
|---|---|---|---|
| 1 | MedPlus Health Services Limited ₹2.30 Cr |
Retailing | 0.88% |
| 2 | VENUS PIPES & TUBES LTD ₹1.83 Cr |
Industrial Products | 0.69% |
| 3 | Bharat Dynamics Limited ₹1.24 Cr |
Aerospace & Defense | 0.47% |
| 4 | Yes Bank Limited ₹1.20 Cr |
Banks | 0.46% |
| # | Stock | Sector | Jul 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | Divi's Laboratories Limited ₹25.30 Cr |
Pharmaceuticals & Biotechnology | 7.97% | 9.51% | +1.54% |
| 2 | Sai Life Sciences Limited ₹4.97 Cr |
Pharmaceuticals & Biotechnology | 1.32% | 1.87% | +0.55% |
| 3 | Shilpa Medicare Ltd ₹4.29 Cr |
Pharmaceuticals & Biotechnology | 1.15% | 1.61% | +0.46% |
| 4 | IPCA Laboratories Limited ₹5.17 Cr |
Pharmaceuticals & Biotechnology | 1.50% | 1.94% | +0.44% |
| 5 | Mankind Pharma Limited ₹10.05 Cr |
Pharmaceuticals & Biotechnology | 3.39% | 3.78% | +0.39% |
| 6 | Dr. Reddy's Laboratories Limited ₹12.72 Cr |
Pharmaceuticals & Biotechnology | 4.41% | 4.78% | +0.37% |
| 7 | Healthcare Global Enterprises Limited ₹3.90 Cr |
Healthcare Services | 1.21% | 1.47% | +0.26% |
| 8 | Abbott India Limited ₹5.70 Cr |
Pharmaceuticals & Biotechnology | 1.90% | 2.14% | +0.24% |
| 9 | Aster DM Healthcare Limited ₹4.24 Cr |
Healthcare Services | 1.35% | 1.59% | +0.24% |
| 10 | Aurobindo Pharma Limited ₹10.68 Cr |
Pharmaceuticals & Biotechnology | 3.84% | 4.01% | +0.17% |
| # | Stock | Sector | Jul 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited ₹31.82 Cr |
Pharmaceuticals & Biotechnology | 13.26% | 11.96% | -1.30% |
| 2 | Lupin Limited ₹5.43 Cr |
Pharmaceuticals & Biotechnology | 2.82% | 2.04% | -0.78% |
| 3 | Apollo Hospitals Enterprise Limited ₹14.49 Cr |
Healthcare Services | 6.05% | 5.45% | -0.60% |
| 4 | Max Healthcare Institute Limited ₹11.93 Cr |
Healthcare Services | 5.05% | 4.49% | -0.56% |
| 5 | Cipla Limited ₹11.14 Cr |
Pharmaceuticals & Biotechnology | 4.43% | 4.19% | -0.24% |
| 6 | Laurus Labs Limited ₹10.70 Cr |
Pharmaceuticals & Biotechnology | 4.21% | 4.02% | -0.19% |
| 7 | Linde India Limited ₹2.45 Cr |
Chemicals & Petrochemicals | 1.10% | 0.92% | -0.18% |
| 8 | Biocon Limited ₹2.17 Cr |
Pharmaceuticals & Biotechnology | 0.95% | 0.81% | -0.14% |
| 9 | Global Health Limited ₹7.59 Cr |
Healthcare Services | 2.98% | 2.85% | -0.13% |
| 10 | Torrent Pharmaceuticals Limited ₹12.71 Cr |
Pharmaceuticals & Biotechnology | 4.84% | 4.78% | -0.06% |
37 stocks — Sep 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹31.82 Cr |
Pharmaceuticals & Biotechnology |
11.96%
|
|
| 2 |
₹25.30 Cr |
Pharmaceuticals & Biotechnology |
9.51%
|
|
| 3 |
₹14.49 Cr |
Healthcare Services |
5.45%
|
|
| 4 |
₹12.71 Cr |
Pharmaceuticals & Biotechnology |
4.78%
|
|
| 5 |
₹12.72 Cr |
Pharmaceuticals & Biotechnology |
4.78%
|
|
| 6 |
₹11.93 Cr |
Healthcare Services |
4.49%
|
|
| 7 |
₹11.14 Cr |
Pharmaceuticals & Biotechnology |
4.19%
|
|
| 8 |
₹10.70 Cr |
Pharmaceuticals & Biotechnology |
4.02%
|
|
| 9 |
₹10.68 Cr |
Pharmaceuticals & Biotechnology |
4.01%
|
|
| 10 |
₹10.05 Cr |
Pharmaceuticals & Biotechnology |
3.78%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.